ACC CardiaCast: Risk Assessment and Treatment of Hypertriglyceridemia

Aug 07, 2026   |  Michael D. Shapiro, DO, FACC; Carol F. Kirkpatrick, PhD, MPH, RDN, CLS; Salim S. Virani, MD, FACC

Podcast
Print
Font Size
A
A
A
On this page:
Resources

This episode of CardiaCast will feature a discussion on risk assessment and the treatment of hypertriglyceridemia.

This podcast is supported by Esperion, Merck, and Novartis.

Related References:

  1. Blumenthal, R, Morris, P, Gaudino, M. et al. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. JACC. 2026 May, 87 (19) 2624–2757.
Subscribe to the CardiaCast Podcast

Resources

Clinical Topics: Diabetes and Cardiometabolic Disease, Dyslipidemia, Prevention, Hypertriglyceridemia

Keywords: CardiaCast, Primary Prevention, Secondary Prevention, Risk Assessment, Hypertriglyceridemia, Dyslipidemia, Plaque, Atherosclerotic